Bicyclic pyridine and pyrimidine p38 kinase inhibitors

Details Bicyclic pyridine and pyrimidine p38 kinase inhibitors Bicyclic pyridine and pyrimidine p38 kinase inhibitors

2006-08-15

2006-08-15

McKenzie, Thomas C. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S280000, C514S260100, C514S265100

Reexamination Certificate

active

07091347

ABSTRACT:
The present invention discloses compounds corresponding to formulawherein A, R, X, Y, R, R1and R2are as defined above, pharmaceutical formulations, methods of making and uses thereof.

REFERENCES:
patent: 4835157 (1989-05-01), Press et al.
patent: 2001/0020030 (2001-09-01), Stewart et al.
patent: WO 95/29897 (1995-11-01), None
patent: WO 95/33748 (1995-12-01), None
patent: WO 95/33752 (1995-12-01), None
patent: WO 98/01428 (1998-01-01), None
patent: WO 98/08382 (1998-03-01), None
patent: WO 00/39108 (2000-07-01), None
patent: WO 00/43394 (2000-07-01), None
patent: WO 01/49688 (2001-07-01), None
patent: WO 02/14317 (2002-02-01), None
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
J. W. Fijen*, J. G. Zijlstra*, P. De Boer, R. Spanjersberg*, J. W. Cohen Tervaert , T. S. Van Der Werf*, J. J. M. Ligtenberg* & J. E. Tulleken*, Clinical & Experimental Immunology vol. 124 Issue 1 pp. 16—Apr. 2001.
Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, Tytgat G, Peppelenbosch M, Van Deventer S., Gastroenterology. Jan. 2002;122(1):7-14..PMID: abstract 11781274.
Hashimoto S, Gon Y, Matsumoto K, Maruoka S, Takeshita I, Hayashi S, Asai Y, Jibiki I, Machino T, Horie T., J Pharmacol Exp Ther. May 2000;293(2):370-5.
Hurst, Derek T. An Introduction to the Chemistry and Biochemistry of the Pyrimidines, Purines, and Pteridines, London: John Wiley and Sons. 1980 pp. 26-27.
Ganghyeok Kim et al, “Design, Synthesis, and Evaluation of 1,5-Disu”,Array Biopharma, [online] no date [retrieved on Apr. 28, 2005]. Retrieved from the Internet, <http://media.corporate-ir.net/media—files
sd/arry/posters/0304ACS-Anaheim-Poster.pdf>.
Michael Greer, “HIV/AIDS Dementia: CPI-1189 safe but ineffective”, AIDSWEEKLY Plus; [online] AIDSWEEKLY Plus; Monday, Jan. 20, 2003 [retrieved on Apr. 28, 2005]. Retrieved from the Internet, <http://www.aegis.com/pubs/aidswkly/2003/AW030107.html>.
Henry, James R., et al., “6-Amino-2-(4-fluorophenyl)-4-methoxy-3-(4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354): A Potent and Selective p38 Kinase Inhibitor”,J. Med. Chem, 1998, 41: 4196-4198.
Koch, A., et al., “Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages”,Eur. Respir. J., 2004, 23: 805-812.
Noble, Martin E. M., et al., “Protein Kinase Inhibitors: Insights into Drug Design from Structure”, Science, 2004, 303: 1800-1804.
Trejo, Alejandra, et al., “Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase”,J. Med. Chem., 2003, 46: 4702-4713.

Affiliated with

Also associated with

Rating

Bicyclic pyridine and pyrimidine p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic pyridine and pyrimidine p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic pyridine and pyrimidine p38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3633909